Dialyzable Leukocyte Extract (Transfer Factor) as Adjuvant Immunotherapy in the Treatment of Cancer

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  2016-10-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.15406/MOJAD.2016.1.00003
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Transfer factor: an overlooked potential for the prevention and treatment of infectious diseases.

  2013cited by this paper
• A review on transfer factor an immune modulator

  2013cited by this paper
• Clinical and immunological assessment in breast cancer patients receiving anticancer therapy and bovine dialyzable leukocyte extract as an adjuvant.

  2010cited by this paper
• Fructose‐induced N‐terminal glycation of enkephalins and related peptides

  2008cited by this paper
• Bovine dialyzable leukocyte extract modulates AP-1 DNA-binding activity and nuclear transcription factor expression in MCF-7 breast cancer cells.

  2008cited by this paper
• Indications, usage, and dosage of the transfer factor.

  2007cited by this paper
• In Vitro Antibacterial Activity of Bovine Dialyzable Leukocyte Extract

  2006cited by this paper
• In vitro effects of bovine dialyzable leukocyte extract (bDLE) in cancer cells.

  2006cited by this paper
• Ultrafiltered Pig Leukocyte Extract (UPLE, IMUNOR®) Potentiates Hematopoiesis–Stimulating Effects of G-CSF In Vitro and Improves the Outcome of Treatment of Hematopoietic Radiation Damage in Mice with G-CSF

  2005cited by this paper
• Direct Colorimetric Assay for Rapid Detection of Rifampin-Resistant Mycobacterium tuberculosis

  2004cited by this paper
• NF-kappaB action in sepsis: the innate immune system and the heart.

  2004cited by this paper
• Cancer and Complementary and Alternative Medicine in Italy: Personal Observations and Historical Considerations

  2004cited by this paper
• Dialyzable Leukocyte Extract differentially regulates the production of TNFα, IL-6, and IL-8 in bacterial component-activated leukocytes and endothelial cells

  2004cited by this paper
• Rapid deterioration in quality of life during interleukin-2- and α-interferon-based home therapy of renal cell carcinoma is associated with a good outcome

  2003cited by this paper
• Dialyzable leukocyte extract suppresses the activity of essential transcription factors for HIV-1 gene expression in unstimulated MT-4 cells.

  2000cited by this paper
• Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades.

  2000cited by this paper
• Comparative study of transfer factor and acyclovir in the treatment of herpes zoster.

  1998cited by this paper
• Dialysable leucocyte extract (DLE) reduces lipopolysaccharide- induced tumour necrosis factor secretion in human leucocytes

  1996cited by this paper
• Some properties and protective activity of specific DLE against Salmonella cholerae suis infection

  1996cited by this paper
• Transfer factor 1993: new frontiers.

  1994cited by this paper
• Structural Nature and Functions of Transfer Factors

  1993cited by this paper
• Purification of transfer factors.

  1992cited by this paper
• Transfer factor for adjuvant immunotherapy in cervical cancer.

  1987cited by this paper
• Murine transfer factor. II. Transfer of delayed hypersensitivity to synthetic antigens.

  1985cited by this paper
• Biochemistry and Distribution of the T Cell Receptor

  1984cited by this paper
• Randomized controlled trial of transfer factor in stage II malignant melanoma

  1983cited by this paper
• In vitro determination of effects of dialyzable leukocyte extracts containing transfer factor activity.

  1982cited by this paper
• Chemoimmunotherapy of disseminated malignant melanoma with DTIC‐BCG, transfer factor + melphalan

  1980cited by this paper
• Comparative studies on dialyzable leukocyte extracts containing transfer factor--a review.

  1980cited by this paper
• [Effect of transfer factor on the immunity state of patients with bronchopulmonary cancer. A report on 12 cases (author's transl)].

  1979cited by this paper
• Cancer immunotherapy: Facts and fancy

  1979cited by this paper
• Neuroblastoma and transfer factor.

  1977cited by this paper
• [In-vitro studies with human transfer factor].

  1977cited by this paper
• Human transfer factor: fractionation by electrofocusing and high pressure, reverse phase chromatography.

  1977cited by this paper
• Immunotherapy of disseminated renal cell carcinoma with transfer factor.

  1977cited by this paper
• DIALYZABLE TRANSFER FACTOR IN THE TREATMENT OF HUMAN OSTEOSARCOMA: AN ANALYTIC REVIEW *

  1976cited by this paper
• Osteogenic sarcoma. Immunologic parameters before and during immunotherapy with tumor-specific transfer factor.

  1975cited by this paper
• Chemotactic activity in dialyzable transfer factor.

  1974cited by this paper
• Effects of dialyzable transfer factor in patients with breast cancer.

  1974cited by this paper
• Nature of "transfer factor".

  1973cited by this paper
• Studies on the transfer of human delayed-type hypersensitivity. I. Partial purification and characterization of two active components.

  1966influential reference
• Chromatography of the human tuberculin delayed-type hypersensitivity transfer factor.

  1962cited by this paper
• Transfer of delayed hypersensitivity to coccidioidin in man.

  1960cited by this paper
• The transfer in humans of delayed skin sensitivity to streptococcal M substance and to tuberculin with disrupted leucocytes.

  1955cited by this paper
• Passive Transfer of Delayed Hypersensitivity to 2,4-Dinitrochlorobenzene in Guinea Pigs with Leucocytic Extracts.∗

  1954cited by this paper

• Characterization and Safety Profile of Transfer Factors Peptides, a Nutritional Supplement for Immune System Regulation

  2021cites this paper
• Postulated Adjuvant Therapeutic Strategies for COVID-19

  2020cites this paper
• Effect of Sublingual Isolated Transfer Factors in a Case of Therapy Resistant Periungual Warts

  2020cites this paper
• Immunoregulatory effects of Imuno TF® (transfer factors) on Th1/Th2/Th17/Treg cytokines

  2020cites this paper
• Characterization and safety profile of Imuno TF®, a nutritional supplement for immune system regulation containing transfer factors

  2020cites this paper
• Immunologic Improvement of Vaccine for Newcastle Disease via Co-Inoculation of Cattle Transfer Factor in Broilers

  2020cites this paper